Sort
25,944 grants matching “neurodegeneration”
Stem cells and aging
$1,191,414Toren Finkel · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL
The role of autophagy in aging and metabolism
$1,191,414Toren Finkel · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL
Molecular and anatomical characterization of cell types in the aging mouse brain
$1,191,386Hongkui Zeng · Allen Institute · R01 · FY2020 · AG
Nuclear and Glial Dysfunction in Neurodegeneration
$1,191,282Jeffrey D Rothstein · Johns Hopkins University · R35 · FY2024 · NS
Neuroprotective signaling and transcriptional pathways in microglia associated with Alzheimer's disease
$1,191,261Alison M Goate · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · AG
Dissecting the role of sex-linked genes and APOE e4 risk in AD
$1,190,459Jessica Elaine Young · University Of Washington · R01 · FY2022 · AG
Dissecting the role of sex-linked genes and APOE e4 risk in AD
$1,190,459Jessica Elaine Young · University Of Washington · R01 · FY2024 · AG
Dissecting the role of sex-linked genes and APOE e4 risk in AD
$1,190,459Jessica Elaine Young · University Of Washington · R01 · FY2023 · AG
Dissecting the role of sex-linked genes and APOE e4 risk in AD
$1,190,459Jessica Elaine Young · University Of Washington · R01 · FY2021 · AG
Development of Therapeutic Antibody for Traumatic Brain Injury
$1,190,138Mark L. Zeidel · Beth Israel Deaconess Medical Center · U01 · FY2019 · NS
Axonal transport regulates synaptic function and axonal homeostasis
$1,188,968Zu-Hang Sheng · National Institute Of Neurological Disorders And Stroke · ZIA · FY2014 · NS
TDP-43 Proteinopathies in ALS-Dementia
$1,187,434Virginia M Lee · University Of Pennsylvania · P01 · FY2010 · AG
Characterizing Cognitive Decline in Late Life Depression: The ADNI-D Project
$1,185,537Robert Scott Mackin · University Of California, San Francisco · R01 · FY2022 · MH
Tissue Injury and Inflammation in Multiple Sclerosis
$1,184,550Richard M Ransohoff · Cleveland Clinic Lerner Com-Cwru · P01 · FY2007 · NS
New targeted BDNF nanoparticles for treatment of METH addiction and neurotoxicity
$1,184,259Franco Vitaliano · Exqor Technologies, Inc. · R44 · FY2022 · DA
Development of a Synthetic, Cell-Permeable Peptide for the Inhibition of CDK5-p25 Hyperactivity in Amyotrophic Lateral Sclerosis
$1,183,364John Kent Werner · Cogentis Therapeutics, Inc. · R44 · FY2021 · NS
Molecular Roles of Cdk5 in Neuronal Functions and Pain Signaling
$1,183,074Ashok Kulkarni · National Institute Of Dental & Craniofacial Research · ZIA · FY2014 · DE
Oxidative DNA Damage And Its Processing
$1,182,793Vilhelm A Bohr · National Institute On Aging · ZIA · FY2021 · AG
PREQUEL Study In PRE-manifest HD of CoQ10/UbiquinonE Leading to Preventive Trials
$1,182,774Christopher A Ross · Johns Hopkins University · R01 · FY2008 · NS
Molecular Basis for the Pathogenesis of Murine Retroviruses
$1,181,952Sandra K Ruscetti · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Phase 1 Trial to Assess Safety and Immune Effects of Xenon Gas in Healthy Human Subjects
$1,181,555Ilya Ilin · General Biophysics, Llc · R42 · FY2024 · AG
Homeostatic Stabilization of Neural Function in Health and Disease
$1,181,411Graeme W Davis · University Of California, San Francisco · R35 · FY2019 · NS
Homeostatic Stabilization of Neural Function in Health and Disease
$1,181,219Graeme W Davis · University Of California, San Francisco · R35 · FY2020 · NS
Homeostatic Stabilization of Neural Function in Health and Disease
$1,181,219Graeme W Davis · University Of California, San Francisco · R35 · FY2023 · NS
Cell Models for AD: Lipids and Related Signaling Pathways
$1,180,907Grace Y Sun · University Of Missouri-Columbia · P01 · FY2010 · AG